Global and Region Obsessive-Compulsive Disorder Treatment Market Demand & Opportunity Outlook 2022-2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The report details the trend, potential and market size of Obsessive-Compulsive Disorder Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Obsessive-Compulsive Disorder Treatmentmarket, defines the market attractiveness level of Obsessive-Compulsive Disorder Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Obsessive-Compulsive Disorder Treatment industry, describes the types of Obsessive-Compulsive Disorder Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Obsessive-Compulsive Disorder Treatment market and the development prospects and opportunities of Obsessive-Compulsive Disorder Treatment industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Obsessive-Compulsive Disorder Treatment market in Chapter 13.

    By Player:

    • F Hoffmann-La Roche Ltd

    • Novartis AG

    • AbbVie Inc

    • Omeros Corporation

    • Addex Therapeutics Ltd

    • C4X Discovery Limited

    • Sellas Inc

    • Rottapharm SpA

    By Type:

    • ADX-88178

    • Bitopertin

    • CR-5542

    • Dipraglurant IR

    • Fluvoxamine Maleate

    • Mavoglurant

    • Others

    By End-User:

    • Clinic

    • Hospital

    • Research Center

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Obsessive-Compulsive Disorder Treatment Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Obsessive-Compulsive Disorder Treatment Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Obsessive-Compulsive Disorder Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Obsessive-Compulsive Disorder Treatment Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Obsessive-Compulsive Disorder Treatment Market Analysis and Outlook to 2022

    • 7.1 Global Obsessive-Compulsive Disorder Treatment Consumption (2017-2022)

    • 7.2 United States Obsessive-Compulsive Disorder Treatment Consumption (2017-2022)

    • 7.3 Europe Obsessive-Compulsive Disorder Treatment Consumption (2017-2022)

    • 7.4 China Obsessive-Compulsive Disorder Treatment Consumption (2017-2022)

    • 7.5 Japan Obsessive-Compulsive Disorder Treatment Consumption (2017-2022)

    • 7.6 India Obsessive-Compulsive Disorder Treatment Consumption (2017-2022)

    • 7.7 South Korea Obsessive-Compulsive Disorder Treatment Consumption (2017-2022)

    8 Region and Country-wise Obsessive-Compulsive Disorder Treatment Market Analysis and Outlook to 2028

    • 8.1 Global Obsessive-Compulsive Disorder Treatment Consumption Forecast (2022-2028)

    • 8.2 United States Obsessive-Compulsive Disorder Treatment Consumption Forecast (2022-2028)

    • 8.3 Europe Obsessive-Compulsive Disorder Treatment Consumption Forecast (2022-2028)

    • 8.4 China Obsessive-Compulsive Disorder Treatment Consumption Forecast (2022-2028)

    • 8.5 Japan Obsessive-Compulsive Disorder Treatment Consumption Forecast (2022-2028)

    • 8.6 India Obsessive-Compulsive Disorder Treatment Consumption Forecast (2022-2028)

    • 8.7 South Korea Obsessive-Compulsive Disorder Treatment Consumption Forecast (2022-2028)

    9 Global Obsessive-Compulsive Disorder Treatment Market Outlook by Types and Applications to 2022

    • 9.1 Global Obsessive-Compulsive Disorder Treatment Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global ADX-88178 Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Bitopertin Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global CR-5542 Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Dipraglurant IR Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Fluvoxamine Maleate Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Mavoglurant Consumption and Growth Rate (2017-2022)

      • 9.1.7 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Obsessive-Compulsive Disorder Treatment Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Clinic Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Research Center Consumption and Growth Rate (2017-2022)

    10 Global Obsessive-Compulsive Disorder Treatment Market Outlook by Types and Applications to 2028

    • 10.1 Global Obsessive-Compulsive Disorder Treatment Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global ADX-88178 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Bitopertin Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global CR-5542 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Dipraglurant IR Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Fluvoxamine Maleate Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.6 Global Mavoglurant Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.7 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Obsessive-Compulsive Disorder Treatment Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Clinic Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Research Center Consumption Forecast and Growth Rate (2022-2028)

    11 Global Obsessive-Compulsive Disorder Treatment Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Obsessive-Compulsive Disorder Treatment Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Obsessive-Compulsive Disorder Treatment Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Obsessive-Compulsive Disorder Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Obsessive-Compulsive Disorder Treatment Market Competitive Analysis

    • 14.1 F Hoffmann-La Roche Ltd

      • 14.1.1 F Hoffmann-La Roche Ltd Company Details

      • 14.1.2 F Hoffmann-La Roche Ltd Obsessive-Compulsive Disorder Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 F Hoffmann-La Roche Ltd Obsessive-Compulsive Disorder Treatment Product and Service

    • 14.2 Novartis AG

      • 14.2.1 Novartis AG Company Details

      • 14.2.2 Novartis AG Obsessive-Compulsive Disorder Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Novartis AG Obsessive-Compulsive Disorder Treatment Product and Service

    • 14.3 AbbVie Inc

      • 14.3.1 AbbVie Inc Company Details

      • 14.3.2 AbbVie Inc Obsessive-Compulsive Disorder Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 AbbVie Inc Obsessive-Compulsive Disorder Treatment Product and Service

    • 14.4 Omeros Corporation

      • 14.4.1 Omeros Corporation Company Details

      • 14.4.2 Omeros Corporation Obsessive-Compulsive Disorder Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Omeros Corporation Obsessive-Compulsive Disorder Treatment Product and Service

    • 14.5 Addex Therapeutics Ltd

      • 14.5.1 Addex Therapeutics Ltd Company Details

      • 14.5.2 Addex Therapeutics Ltd Obsessive-Compulsive Disorder Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Addex Therapeutics Ltd Obsessive-Compulsive Disorder Treatment Product and Service

    • 14.6 C4X Discovery Limited

      • 14.6.1 C4X Discovery Limited Company Details

      • 14.6.2 C4X Discovery Limited Obsessive-Compulsive Disorder Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 C4X Discovery Limited Obsessive-Compulsive Disorder Treatment Product and Service

    • 14.7 Sellas Inc

      • 14.7.1 Sellas Inc Company Details

      • 14.7.2 Sellas Inc Obsessive-Compulsive Disorder Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Sellas Inc Obsessive-Compulsive Disorder Treatment Product and Service

    • 14.8 Rottapharm SpA

      • 14.8.1 Rottapharm SpA Company Details

      • 14.8.2 Rottapharm SpA Obsessive-Compulsive Disorder Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Rottapharm SpA Obsessive-Compulsive Disorder Treatment Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Obsessive-Compulsive Disorder Treatment

    • Figure Obsessive-Compulsive Disorder Treatment Picture

    • Table Global Obsessive-Compulsive Disorder Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Obsessive-Compulsive Disorder Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Obsessive-Compulsive Disorder Treatment Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Obsessive-Compulsive Disorder Treatment Consumption by Country (2017-2022)

    • Figure United States Obsessive-Compulsive Disorder Treatment Consumption and Growth Rate (2017-2022)

    • Table Europe Obsessive-Compulsive Disorder Treatment Consumption and Growth Rate (2017-2022)

    • Figure China Obsessive-Compulsive Disorder Treatment Consumption and Growth Rate (2017-2022)

    • Figure Japan Obsessive-Compulsive Disorder Treatment Consumption and Growth Rate (2017-2022)

    • Figure India Obsessive-Compulsive Disorder Treatment Consumption and Growth Rate (2017-2022)

    • Figure South Korea Obsessive-Compulsive Disorder Treatment Consumption and Growth Rate (2017-2022)

    • Figure Global Obsessive-Compulsive Disorder Treatment Consumption Forecast by Country (2022-2028)

    • Figure United States Obsessive-Compulsive Disorder Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Obsessive-Compulsive Disorder Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Obsessive-Compulsive Disorder Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Obsessive-Compulsive Disorder Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Obsessive-Compulsive Disorder Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Obsessive-Compulsive Disorder Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global ADX-88178 Consumption and Growth Rate (2017-2022)

    • Figure Global Bitopertin Consumption and Growth Rate (2017-2022)

    • Figure Global CR-5542 Consumption and Growth Rate (2017-2022)

    • Figure Global Dipraglurant IR Consumption and Growth Rate (2017-2022)

    • Figure Global Fluvoxamine Maleate Consumption and Growth Rate (2017-2022)

    • Figure Global Mavoglurant Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Clinic Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Research Center Consumption and Growth Rate (2017-2022)

    • Figure Global ADX-88178 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Bitopertin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global CR-5542 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Dipraglurant IR Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Fluvoxamine Maleate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Mavoglurant Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Research Center Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Obsessive-Compulsive Disorder Treatment Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Obsessive-Compulsive Disorder Treatment Export by Region (Top 5 Countries) (2017-2028)

    • Table F Hoffmann-La Roche Ltd (Foundation Year, Company Profile and etc.)

    • Table F Hoffmann-La Roche Ltd Obsessive-Compulsive Disorder Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table F Hoffmann-La Roche Ltd Obsessive-Compulsive Disorder Treatment Product and Service

    • Table Novartis AG (Foundation Year, Company Profile and etc.)

    • Table Novartis AG Obsessive-Compulsive Disorder Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis AG Obsessive-Compulsive Disorder Treatment Product and Service

    • Table AbbVie Inc (Foundation Year, Company Profile and etc.)

    • Table AbbVie Inc Obsessive-Compulsive Disorder Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table AbbVie Inc Obsessive-Compulsive Disorder Treatment Product and Service

    • Table Omeros Corporation (Foundation Year, Company Profile and etc.)

    • Table Omeros Corporation Obsessive-Compulsive Disorder Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Omeros Corporation Obsessive-Compulsive Disorder Treatment Product and Service

    • Table Addex Therapeutics Ltd (Foundation Year, Company Profile and etc.)

    • Table Addex Therapeutics Ltd Obsessive-Compulsive Disorder Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Addex Therapeutics Ltd Obsessive-Compulsive Disorder Treatment Product and Service

    • Table C4X Discovery Limited (Foundation Year, Company Profile and etc.)

    • Table C4X Discovery Limited Obsessive-Compulsive Disorder Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table C4X Discovery Limited Obsessive-Compulsive Disorder Treatment Product and Service

    • Table Sellas Inc (Foundation Year, Company Profile and etc.)

    • Table Sellas Inc Obsessive-Compulsive Disorder Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sellas Inc Obsessive-Compulsive Disorder Treatment Product and Service

    • Table Rottapharm SpA (Foundation Year, Company Profile and etc.)

    • Table Rottapharm SpA Obsessive-Compulsive Disorder Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Rottapharm SpA Obsessive-Compulsive Disorder Treatment Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.